Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.

Silvestri GA, Vachani A, Whitney D, Elashoff M, Porta Smith K, Ferguson JS, Parsons E, Mitra N, Brody J, Lenburg ME, Spira A; AEGIS Study Team.

N Engl J Med. 2015 Jul 16;373(3):243-51. doi: 10.1056/NEJMoa1504601. Epub 2015 May 17.

2.

Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.

Whitney DH, Elashoff MR, Porta-Smith K, Gower AC, Vachani A, Ferguson JS, Silvestri GA, Brody JS, Lenburg ME, Spira A.

BMC Med Genomics. 2015 May 6;8:18. doi: 10.1186/s12920-015-0091-3.

3.

Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response.

Pierceall WE, Warner SL, Lena RJ, Doykan C, Blake N, Elashoff M, Hoff DV, Bearss DJ, Cardone MH, Andritsos L, Byrd JC, Lanasa MC, Grever MR, Johnson AJ.

Leukemia. 2014 Nov;28(11):2251-4. doi: 10.1038/leu.2014.206. Epub 2014 Jul 3. No abstract available.

4.

Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia.

Pierceall WE, Lena RJ, Medeiros BC, Blake N, Doykan C, Elashoff M, Cardone MH, Walter RB.

Leuk Res. 2014 May;38(5):564-8. doi: 10.1016/j.leukres.2014.02.007. Epub 2014 Feb 28.

5.

A peripheral blood gene expression score is associated with atherosclerotic Plaque Burden and Stenosis by cardiovascular CT-angiography: results from the PREDICT and COMPASS studies.

Voros S, Elashoff MR, Wingrove JA, Budoff MJ, Thomas GS, Rosenberg S.

Atherosclerosis. 2014 Mar;233(1):284-90. doi: 10.1016/j.atherosclerosis.2013.12.045. Epub 2014 Jan 20.

6.

Personalized reproductive medicine on the brink: progress, opportunities and challenges ahead.

Beim PY, Elashoff M, Hu-Seliger TT.

Reprod Biomed Online. 2013 Dec;27(6):611-23. Review.

PMID:
24449934
7.

Clinical implications of referral bias in the diagnostic performance of exercise testing for coronary artery disease.

Ladapo JA, Blecker S, Elashoff MR, Federspiel JJ, Vieira DL, Sharma G, Monane M, Rosenberg S, Phelps CE, Douglas PS.

J Am Heart Assoc. 2013 Dec 13;2(6):e000505. doi: 10.1161/JAHA.113.000505. Review.

8.

A peripheral blood gene expression score is associated with plaque volume and phenotype by intravascular ultrasound with radiofrequency backscatter analysis: results from the ATLANTA study.

Joshi PH, Rinehart S, Vazquez G, Qian Z, Sharma A, Anderson H, Murrieta L, Flockhart N, Karmpaliotis D, Kalynych A, Asztalos B, Elashoff MR, Blanchard J, Rosenberg S, Brown C 3rd, Voros S.

Cardiovasc Diagn Ther. 2013 Mar;3(1):5-14. doi: 10.3978/j.issn.2223-3652.2013.01.02.

9.

Apoprotein B, small-dense LDL and impaired HDL remodeling is associated with larger plaque burden and more noncalcified plaque as assessed by coronary CT angiography and intravascular ultrasound with radiofrequency backscatter: results from the ATLANTA I study.

Voros S, Joshi P, Qian Z, Rinehart S, Vazquez-Figueroa JG, Anderson H, Elashoff M, Murrieta L, Karmpaliotis D, Kalynych A, Brown C 3rd, Schaefer E, Asztalos B.

J Am Heart Assoc. 2013 Nov 19;2(6):e000344. doi: 10.1161/JAHA.113.000344.

10.

BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia.

Pierceall WE, Kornblau SM, Carlson NE, Huang X, Blake N, Lena R, Elashoff M, Konopleva M, Cardone MH, Andreeff M.

Mol Cancer Ther. 2013 Dec;12(12):2940-9. doi: 10.1158/1535-7163.MCT-13-0692. Epub 2013 Oct 3.

11.

A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe?

Butler PC, Elashoff M, Elashoff R, Gale EA.

Diabetes Care. 2013 Jul;36(7):2118-25. doi: 10.2337/dc12-2713. Epub 2013 May 3.

12.

A blood-based gene expression test for obstructive coronary artery disease tested in symptomatic nondiabetic patients referred for myocardial perfusion imaging the COMPASS study.

Thomas GS, Voros S, McPherson JA, Lansky AJ, Winn ME, Bateman TM, Elashoff MR, Lieu HD, Johnson AM, Daniels SE, Ladapo JA, Phelps CE, Douglas PS, Rosenberg S.

Circ Cardiovasc Genet. 2013 Apr;6(2):154-62. doi: 10.1161/CIRCGENETICS.112.964015. Epub 2013 Feb 15.

13.

A whole blood gene expression-based signature for smoking status.

Beineke P, Fitch K, Tao H, Elashoff MR, Rosenberg S, Kraus WE, Wingrove JA; PREDICT Investigators.

BMC Med Genomics. 2012 Dec 3;5:58. doi: 10.1186/1755-8794-5-58.

14.

A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial.

Lansky A, Elashoff MR, Ng V, McPherson J, Lazar D, Kraus WE, Voros S, Schwartz RS, Topol EJ.

Am Heart J. 2012 Sep;164(3):320-6. doi: 10.1016/j.ahj.2012.05.012. Epub 2012 Jul 24.

PMID:
22980297
15.

Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab.

Wagner CL, Visvanathan S, Elashoff M, McInnes IB, Mease PJ, Krueger GG, Murphy FT, Papp K, Gomez-Reino JJ, Mack M, Beutler A, Gladman D, Kavanaugh A.

Ann Rheum Dis. 2013 Jan;72(1):83-8. doi: 10.1136/annrheumdis-2012-201697. Epub 2012 Sep 12.

16.

Identification of factors contributing to variability in a blood-based gene expression test.

Elashoff MR, Nuttall R, Beineke P, Doctolero MH, Dickson M, Johnson AM, Daniels SE, Rosenberg S, Wingrove JA.

PLoS One. 2012;7(7):e40068. doi: 10.1371/journal.pone.0040068. Epub 2012 Jul 3.

17.

Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial.

Rosenberg S, Elashoff MR, Lieu HD, Brown BO, Kraus WE, Schwartz RS, Voros S, Ellis SG, Waksman R, McPherson JA, Lansky AJ, Topol EJ; PREDICT Investigators.

J Cardiovasc Transl Res. 2012 Jun;5(3):366-74. doi: 10.1007/s12265-012-9353-z. Epub 2012 Mar 7.

18.

Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab.

Wagner C, Visvanathan S, Braun J, van der Heijde D, Deodhar A, Hsu B, Mack M, Elashoff M, Inman RD.

Ann Rheum Dis. 2012 May;71(5):674-80. doi: 10.1136/ard.2010.148890. Epub 2011 Oct 28.

19.

Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients.

Elashoff MR, Wingrove JA, Beineke P, Daniels SE, Tingley WG, Rosenberg S, Voros S, Kraus WE, Ginsburg GS, Schwartz RS, Ellis SG, Tahirkheli N, Waksman R, McPherson J, Lansky AJ, Topol EJ.

BMC Med Genomics. 2011 Mar 28;4:26. doi: 10.1186/1755-8794-4-26.

20.

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies.

Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC.

Gastroenterology. 2011 Jul;141(1):150-6. doi: 10.1053/j.gastro.2011.02.018. Epub 2011 Feb 18.

Supplemental Content

Loading ...
Support Center